Formulation of Folate Receptor-Targeted Silibinin-Loaded Inhalable Chitosan Nanoparticles by the QbD Approach for Lung Cancer Targeted Delivery
ACS Omega · 05.03.2024 · 9 (9) · 10353-10370
DOI: 10.1021/acsomega.3c07954 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Omega, online erschienen am 24.02.2024. Verfasst von Priya Patel und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, Saurashtra University, Rajkot 360005, Gujarat, India. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Ministry of Education ? Kingdom of Saudi Arabi.
Abstract (Originalsprache)
Aim
Targeted delivery of chemotherapeutics by functionalized nanoparticles exhibits a wonderful prospect for cancer treatment. The main objective of this research was to develop folate receptor-targeted silibinin (SB)-loaded inhalable polymeric nanoparticles (FA-CS-SB-NPs) for the treatment of lung cancer.
Method
The qbD approach was implemented to prepare SB-loaded nanoparticles. Folic acid was conjugated by electrostatic conjugation in an optimized batch. The therapeutic potentials of formulations were determined using a lung cancer cell-bearing rat model.
Result
Optimized formulation exhibited a spherical surface with a mean particle size of 275 ± 1.20 nm, a PDI of 0.234 ± 0.07, a ζ-potential of 32.50 ± 0.21, an entrapment efficiency of 75.52 ± 0.87%, and a CDR of 63.25 ± 1.21% at 48 h. Aerodynamic behaviors such as the mass median aerodynamic diameter (MMAD) and geometric size distribution (GSD) were found to be 2.75 ± 1.02 and 3.15 ± 0.88 μm, respectively. After 24 h of incubation with FA-CS-SB-NPs, the IC50 value was found to be 24.5 g/mL. FA-SB-CS-NPs maintained a significantly higher deposition of SB in lung tissues.
Conclusions
Thus, the noninvasive nature and target specificity of FA-CS-SB-NPs pave the way for pulmonary delivery for treating lung cancer.
Autor:innen und Institutionen
- Department of Pharmaceutical Sciences, Saurashtra University, Rajkot 360005, Gujarat, India.
- Department of Pharmaceutical Sciences, Sardar Patel University, Vallabh Vidya Nagar 388120, Gujarat, India.
- Department of Pharmacology and Toxicology, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh 11451, Saudi Arabia.
- Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia.
- Public Health Research Institute (PHRI), Rutgers, New Jersey Medical School (NJMS), 225 Warren Street, Newark, New Jersey 07103, United States.
- Shree S. K. Patel College of Pharmaceutical Education and Research, Ganpat University, Mehsana 384012, Gujarat, India.
ORCID-Profile: Priya Patel
Förderung
- Ministry of Education ? Kingdom of Saudi Arabi
Zitieren
APA
Patel, P., Raval, M., Airao, V., Ali, N., Shazly, G. A., Khan, R., & Prajapati, B. (2024). Formulation of Folate Receptor-Targeted Silibinin-Loaded Inhalable Chitosan Nanoparticles by the QbD Approach for Lung Cancer Targeted Delivery. ACS Omega, 9(9), 10353-10370. https://doi.org/10.1021/acsomega.3c07954
Vancouver
Patel P, Raval M, Airao V, Ali N, Shazly GA, Khan R, et al. Formulation of Folate Receptor-Targeted Silibinin-Loaded Inhalable Chitosan Nanoparticles by the QbD Approach for Lung Cancer Targeted Delivery. ACS Omega. 2024;9(9):10353-10370. doi:10.1021/acsomega.3c07954
BibTeX
@article{Patel2024,
author = {Patel, Priya and Raval, Mihir and Airao, Vishal and Ali, Nemat and Shazly, Gamal A and Khan, Rehan and Prajapati, Bhupendra},
title = {Formulation of Folate Receptor-Targeted Silibinin-Loaded Inhalable Chitosan Nanoparticles by the QbD Approach for Lung Cancer Targeted Delivery},
journal = {ACS Omega},
year = {2024},
volume = {9},
number = {9},
pages = {10353--10370},
doi = {10.1021/acsomega.3c07954}
}
EUVIMED